ClinicalTrials.Veeva

Menu

MCG Discovery Study in Emergency Departments

S

SB Technology

Status

Enrolling

Conditions

NSTEMI - Non-ST Segment Elevation MI
ACS - Acute Coronary Syndrome

Treatments

Device: Sponsor MCG device

Study type

Interventional

Funder types

Industry

Identifiers

NCT06095557
SB-ACS-002

Details and patient eligibility

About

This prospective discovery study is designed to demonstrate the feasibility of using an unshielded, mobile MCG device in an Emergency Department (ED) setting. The main question it aims to answer is whether interpretable data can be reliably collected as part of an ED workflow.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Presents to ED with symptoms of Acute Coronary Syndrome (ACS)
  • Can provide written consent

Exclusion criteria

  • Presents to ED with ST-Elevation Myocardial Infarction (STEMI)
  • Presents to ED with Atrial Fibrillation
  • Clear non-ischemic cause for symptoms (i.e. trauma)
  • Active thoracic metal implants

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

Sponsor MCG device
Experimental group
Description:
All participants will receive a scan from the Sponsor MCG device
Treatment:
Device: Sponsor MCG device

Trial contacts and locations

1

Loading...

Central trial contact

Kit Yee Au-Yeung, PhD; Maggie LeDang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems